Navigation Links
Detection of Malignant Breast Tumors Made Simpler and More Effective

Scientists linked with Harvard Medical School claim the discovery of a simpler method to distinguish benign breast tumors from malignant ones.//

Harvard’s Kumar R. Bhushan, Ph.D., who led the chemistry group that participated in the research, described details of the new technique today at the 233rd national meeting of the American Chemical society, the world’s largest scientific society.

When used with a non-invasive imaging method that relies on harmless light instead of X-rays, the contrast agent could help doctors diagnose disease within minutes and determine where biopsies are needed.

“Because this agent is highly selective in targeting the product of malignant tumors, this approach may prove most useful for monitoring women who have dense breast tissue, or those who are at a higher-than-average risk for developing a malignant breast tumor,” Frangioni says.

For screening applications, the new technique most likely would be used to supplement, not replace, mammography, according to Frangioni. But the two methods used together, he says, may potentially catch more cancers than mammography alone.

Mammography is still considered the “gold standard” for early detection of breast cancer, but the method often gives false positives, requiring additional screenings and painful biopsies for patients. In addition, studies show that traditional mammograms may miss 10 percent to 20 percent of breast cancers, especially if the tumor is buried in dense tissue.

About half of women under 50 and a third of older women have naturally dense breast tissue, making it harder to distinguish between healthy tissue and questionable masses in mammograms, Frangioni says.

The new agent works by binding to micro-calcifications produced in breast cancers. Though scientists can’t explain exactly why these calcifications occur, studies show that the calcifications in malignant breast tumors contain a higher proportion of a particular calcium salt called hydroxyapatite. In benign tumors, the predominant calcium salt is calcium oxalate.

“By homing in on hydroxyapatite, we can target these malignant cells with a high degree of specificity, and that has the potential to improve the patient’s outcome,” Frangioni says.

The contrast agents are designed using a combination of bisphosphonate, a type of drug used to strengthen bone, with a near-infrared fluorophore. When used with optical tomography, an imaging method that transmits near-infrared light through the body, doctors can reconstruct a three-dimensional image of tissues deep inside the breast, highlighting areas where malignant tumors appear.

The agent also may be used during surgery to pinpoint the location of hydroxyapatite, and therefore the breast cancer cells themselves, Frangioni notes.

His group began working to develop agents to target hydroxyapatite six years ago, but efforts were stalled by the inability to manufacture large quantities of the agent. “It was a chemical catch–22,” he says. “Bisphosphonates are insoluble in anything but water, but to prepare large quantities of the substance for our studies, we need to perform the reaction in the absence of water.”

Future studies will focus on translating the new compound to the clinic for human testing. It will likely be a few years before the compound is ready for use in human trials, according to Frangioni.

Source-Eurkalert
ANN
'"/>




Related medicine news :

1. Detection of Cancer
2. Early Detection Of Prostate Cancer
3. Early Detection of Lung Cancer
4. Early Detection of Prostate Cancer
5. Early Detection Of Facial Abnormalities in a Fetus
6. Early Detection Of Lung Cancer
7. Early Detection Of Breast Cancer
8. Do Not Neglect Your Abdominal Pain/ Swelling - Help Your Doctor In Early Cancer Detection
9. Patient Negligence - Significant Problem In The Early Detection Of Breast Cancer
10. Digital Mammogram For Detection Of Breast Cancer In Women With Dense Breasts
11. Early Detection Of Prostate Cancer For Complete Recovery From Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... 23, 2017 , ... PAINWeekEnd (PWE) Oklahoma City, on April ... will be an educational and exciting program providing busy clinicians and allied healthcare ... pain. , Oklahoma is in a healthcare crisis. The state ranks 46th in ...
(Date:3/23/2017)... ... , ... The MBI “Hall of Fame” recognizes the contributions of those whose careers are or ... the careers of all others involved. , On Monday, March 21st, 2017 Laurie ... of Fame. The induction took place during the World of Modular – Award Gala ...
(Date:3/23/2017)... OH (PRWEB) , ... March ... ... insurance and financial services firm serving the families and businesses of the ... community enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based ...
(Date:3/23/2017)... GA (PRWEB) , ... March 23, 2017 , ... ... the release of SmartBen NOW, an innovative mobile app and centralized benefits dashboard ... and present critical information securely from multiple locations. For the first time, employees ...
(Date:3/23/2017)... ... March 23, 2017 , ... Hakim ... based healthcare technology company California Healthcom Group (CHG). , The HUG investment ... arena. With headquarters in California, CHG is a growing, internationally recognized healthcare management, ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017 Executive Summary ... extensive primary research (inputs from industry experts, companies, ... present the analysis of global heart valve devices ... Repair); Replacement Procedure By Technique (Mechanical, Bioprosthetic, Transcatheter ... Devices, Balloon Valvuloplasty, Transcatheter Mitral Valve Repair (TMVR)), ...
(Date:3/23/2017)... LONDON , March 23, 2017 ... the years along with the prevalence of allergic ... preventative measures are currently revolutionising the ways in ... Allergies 2017 promises to be both ... discussion amongst the allergy interest groups, immunologists, research ...
(Date:3/23/2017)... Summary Global ... guide Primary Hyperoxaluria - Pipeline Review, H1 2017, ... Urinary System And Sex Hormones) pipeline landscape. ... recurrent kidney and bladder stones. It results from ... include blood in the urine, pain when urinating, ...
Breaking Medicine Technology: